SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (358)4/30/2008 9:56:00 AM
From: Biomaven  Respond to of 566
 
human disease is a moving target, patient to patient.

Maybe they can go after an important subset, like lupus nephritis. Less touchy-feely, easily measured and well-understood hard numbers and clinically very significant as well. But still a long and large trial I would guess.

Peter